Peptide profile · Immune
Chonluten
Bronchopulmonary tripeptide bioregulator (Glu-Asp-Gly) that restores respiratory epithelial function through DNA minor groove binding at ATTTC sequences, induces TNF tolerance in alveolar macrophages reducing inflammatory cytokines by up to 6-fold, and normalizes bronchial mucosa differentiation markers in aging lung tissue
Written & reviewed by Michael Carroll · Research, Peptide Initiative
Typical dose
5-10 mg
Half-life
Short plasma half-life typical of tripeptides (minutes to hours); biological effects persist for weeks to months through epigenetic modifications to bronchopulmonary gene expression; metabolized to constituent amino acids
Bioavailability
Absorbed via intestinal peptide transporters (PepT1) in oral formulation with enteric coating; rapid absorption from subcutaneous injection sites; efficient cellular uptake and nuclear penetration due to ultra-short tripeptide structure
Molecular weight
319.27 g/mol
Evidence level
Limited human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C11H17N3O8
Primary benefits
This peptide turns on genes that help your lung lining heal and rebuild, restoring the protective barrier in your airways.
Calms down overactive immune signals in your lungs, reducing harmful inflammation that damages breathing tissue over time.
Long-term Russian studies suggest it may help preserve lung function in older adults, though evidence remains limited outside that research.
Thorne Research Inc.
Amino acid sequence
DGEA-GFOGER-GPQGIAG-GSKGPD02 · Dosing
How much do I take?
5-10 mg · once daily
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Best time to take
Take Chonluten at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
Chonluten can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
If stacking
Chonluten should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
＋ Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
－ Decrease if
- −Side effects are bothersome or impacting daily life despite management strategies
- −You experience any signs of an adverse reaction
- −Lab results indicate the need for dose reduction
- −Your healthcare provider recommends a lower dose based on your response
✓ Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for respiratory health restoration in aging individuals with declining lung function & chronic bronchopulmonary conditions requiring tissue-level regenerative support
Best for
Respiratory health restoration in aging individuals with declining lung function
Chonluten is particularly well-suited for individuals focused on respiratory health restoration in aging individuals with declining lung function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Chronic bronchopulmonary conditions requiring tissue-level regenerative support
Chonluten is particularly well-suited for individuals focused on chronic bronchopulmonary conditions requiring tissue-level regenerative support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Comprehensive Khavinson bioregulator protocols targeting respiratory and immune function
Chonluten is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting respiratory and immune function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Geroprotective therapy for lung tissue preservation in elderly populations
Chonluten is particularly well-suited for individuals focused on geroprotective therapy for lung tissue preservation in elderly populations. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Chonluten with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
Sublingual (enteric-coated capsules) · Subcutaneous injection
Reconstitution — what you need
Example
Chonluten comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Use Chonluten exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Route
Chonluten is administered Sublingual (enteric-coated capsules)—no injection required
Best sites
Technique
- 01Follow the specific administration instructions for your Chonluten formulation
- 02Take or apply as directed by your healthcare provider
- 03Store properly between uses according to package instructions
Storage · before reconstitution
Store Chonluten in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Storage · after reconstitution
Once reconstituted, Chonluten should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
4 common side effects · 2 serious
Chonluten is a cartilage-derived peptide extract used primarily in Russian and Eastern European medicine that lacks FDA approval and rigorous clinical safety data. As a poorly defined mixture of collagen peptides and proteoglycans from cartilage tissue, standardization and batch consistency cannot be guaranteed. Potential risks include allergic reactions to connective tissue proteins, contamination from animal tissues, and unknown immunological effects from proteoglycan components. No formal safety assessments, animal toxicology studies by modern standards, or human Phase 1/2 trials exist. Long-term safety outcomes are completely unstudied.
Evidence is limited to observational clinical use in Russian medical practice spanning several decades and small open-label studies, primarily published in Russian-language journals. No preclinical safety studies, toxicology screening, pharmacokinetics, or randomized controlled trials with formal safety monitoring have been conducted. The literature base consists primarily of descriptive case reports and clinical experience rather than rigorous safety data.
Common side effects · experienced by some users
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with Chonluten
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
Chonluten should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- ✓Vladonix (thymic peptide bioregulator — provides systemic immune support complementing Chonluten's bronchopulmonary specificity) — May be used together under medical guidance.
- ✓Vilon (KE dipeptide — synergistic immunomodulation targeting T-cell function alongside Chonluten's respiratory focus) — May be used together under medical guidance.
- ✓Epithalon (AEDG tetrapeptide — complementary pineal/melatonin bioregulator supporting circadian immune rhythms) — May be used together under medical guidance.
With medications
- !Immunosuppressive medications (cyclosporine, tacrolimus) — Chonluten's immunomodulatory effects may counteract immunosuppression — Use with caution—discuss with your healthcare provider.
- !High-dose systemic corticosteroids — may interfere with Chonluten's bronchial epithelial differentiation mechanisms — Use with caution—discuss with your healthcare provider.
- !Other potent immunostimulants at high doses without medical supervision — risk of immune overactivation in pulmonary tissue — Use with caution—discuss with your healthcare provider.
With supplements
- ✓Multivitamins — Generally safe to take alongside Chonluten. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
06 · Effectiveness
How do I know it's working?
Limited human trials · first signs days 1-10 (during treatment course)
Evidence level
Limited human trials
How it works
Chonluten is a peptide extract designed to support cartilage and joint health by providing building blocks and signaling molecules that promote cartilage cell survival and matrix repair.
Chonluten is a bioactive peptide complex derived from cartilage tissue that contains multiple amino acid sequences and growth factor mimetics capable of activating chondrocyte anabolic pathways. These peptides interact with integrin receptors and growth factor receptors on cartilage cells, upregulating expression of type II collagen, aggrecan, and other extracellular matrix components while simultaneously suppressing catabolic enzymes like matrix metalloproteinases (MMPs) through MAPK and Wnt/β-catenin pathway modulation.
What to expect
Days 1-10 (during treatment course)
What you might notice
- •Minimal noticeable changes initially — epigenetic mechanisms targeting bronchopulmonary genes are building
- •Possible mild injection site reactions or respiratory changes as epithelial remodeling begins
- •Mild fatigue as pulmonary immune function adjusts
- •DNA minor groove binding at ATTTC sequences is activating respiratory gene transcription
What's normal
- •Effects are subtle at first — Chonluten works at the gene expression level through DNA promoter binding
- •Ki-67 and p53 normalization in bronchial epithelium is beginning but cellular turnover takes days to weeks
- •TNF tolerance induction in alveolar macrophages is starting to reduce inflammatory signaling
What's next
- →Continue daily administration for the full course duration (10-20 days)
- →Respiratory improvements will continue building as epithelial differentiation progresses
- →The most significant cellular changes occur during and shortly after the treatment course
Week 2-6 (during and after treatment)
What you might notice
- •Improved respiratory comfort and breathing capacity
- •Enhanced mucociliary clearance and reduced respiratory congestion
- •Better resilience against respiratory infections and environmental irritants
- •Improved energy levels as pulmonary gas exchange normalizes
What's normal
- •Bronchial epithelial differentiation is significantly improved with normalized cell turnover
- •Alveolar macrophage inflammation is substantially reduced through TNF tolerance
- •Pro-inflammatory cytokine levels (IL-1β, IL-6, TNF-α) are markedly decreased
- •These molecular changes translate into functional respiratory improvements over weeks
What's next
- →Benefits continue developing for weeks after the treatment course ends
- →Epigenetic modifications to bronchopulmonary gene expression persist beyond active treatment
- →Plan the next course in 3-6 months to reinforce and extend benefits
Month 2-6 (inter-course period)
What you might notice
- •Sustained improvements in respiratory function and pulmonary defense
- •Ongoing geroprotective benefits from persistent bronchial epithelial normalization
- •Reduced frequency and severity of respiratory issues
- •Benefits may gradually diminish over months, indicating readiness for the next course
What's normal
- •Epigenetic modifications to bronchopulmonary genes persist beyond active treatment
- •Khavinson protocols are designed as cyclical treatments with 3-6 month intervals
- •Each subsequent course reinforces and extends benefits from previous treatments
- •Long-term clinical follow-up supports sustained benefits with repeated courses over years
What's next
- →Begin the next Chonluten course after 3-6 months
- →Consider combining with complementary bioregulators (Vladonix, Epithalon) in rotation
- →Comprehensive anti-aging protocols may use Chonluten alongside other organ-specific peptides
Signs it's working · Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to Chonluten over time
- ✓Reduction in symptom frequency or severity
Signs it's working · General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key research
07 · Questions
Frequently asked
What is Chonluten and what organ does it target?+
Chonluten is a synthetic tripeptide (Glu-Asp-Gly or EDG) classified as T-34 in Khavinson's bioregulator system, specifically designed to target the bronchopulmonary system — the lungs and bronchial tree. It was developed by Professor Vladimir Khavinson as part of his systematic research program identifying organ-specific ultrashort peptides. Chonluten restores respiratory epithelial function through direct DNA interaction at bronchopulmonary gene promoters, normalizing bronchial mucosa differentiation and reducing pulmonary inflammation.
How does Chonluten differ from general immune peptides like Vilon or Thymalin?+
While Vilon (KE dipeptide) and Thymalin provide systemic immune modulation through thymic T-cell activation, Chonluten specifically targets bronchopulmonary tissue. Its EDG sequence binds to ATTTC DNA sequences found in lung-specific gene promoters, activating respiratory epithelial differentiation programs rather than general immune pathways. Think of it as the lung-specialist bioregulator in the Khavinson system, while Vilon is the immune-specialist and Epithalon the pineal-specialist.
Can Chonluten help with chronic respiratory conditions?+
Chonluten has been studied for its ability to restore bronchial epithelial function through normalization of Ki-67 and p53 expression — markers of cell proliferation and apoptosis that become disrupted in chronic respiratory disease. By restoring proper epithelial cell turnover, goblet cell function, and mucociliary clearance, it addresses tissue-level dysfunction underlying chronic respiratory conditions. However, it should not replace established respiratory medications and should be used under medical supervision alongside standard treatments.
Is Chonluten available as an oral supplement?+
Yes, Chonluten is available in enteric-coated capsule form designed for oral administration, in addition to injectable formulations. The oral capsules are manufactured by the Peptide Bioregulator Company and are widely available as dietary supplements in Russia and several CIS countries. The enteric coating protects the EDG tripeptide from gastric degradation, allowing absorption through intestinal peptide transporters.
How does the TNF tolerance mechanism protect the lungs?+
TNF tolerance is a protective adaptation where alveolar macrophages become resistant to excessive TNF-α stimulation while maintaining their ability to respond to pathogens. Chonluten induces this state by modulating MAP kinase phosphorylation and reducing cell-endothelial adhesion in pulmonary tissue. This prevents the damaging cycle of uncontrolled inflammation that occurs in cytokine storms, chronic obstructive conditions, and age-related pulmonary inflammation — essentially training the lung's immune cells to respond proportionally rather than excessively.
What is the recommended treatment schedule for long-term respiratory health?+
The standard Khavinson protocol recommends treatment courses of 10-20 days repeated every 3-6 months. For comprehensive geroprotective therapy, Chonluten is often rotated with complementary bioregulators: Vladonix (thymic/immune), Epithalon (pineal/melatonin), and other organ-specific peptides. Long-term clinical follow-up over 6-8 years has demonstrated sustained benefits with this cyclical approach, including reduced mortality in elderly populations when Chonluten is part of a comprehensive bioregulator program.
08 · Further reading
History & related research
History · since 1994
Restoring the Breath: A Peptide Revolution in Respiratory Medicine
Chonluten is a synthetic tripeptide bioregulator derived from lung tissue, specifically targeting the restoration and normalization of respiratory system function. Developed by Vladimir Khavinson at the St.
Read the full history of Chonluten